551 related articles for article (PubMed ID: 17005662)
1. Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells.
Xin KQ; Mizukami H; Urabe M; Toda Y; Shinoda K; Yoshida A; Oomura K; Kojima Y; Ichino M; Klinman D; Ozawa K; Okuda K
J Virol; 2006 Dec; 80(24):11899-910. PubMed ID: 17005662
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors.
Liu Q; Huang W; Zhang H; Wang Y; Zhao J; Song A; Xie H; Zhao C; Gao D; Wang Y
Gene Ther; 2014 Aug; 21(8):732-8. PubMed ID: 24849042
[TBL] [Abstract][Full Text] [Related]
3. Pre-existing antibodies to candidate gene therapy vectors (adeno-associated vector serotypes) in domestic cats.
Li P; Boenzli E; Hofmann-Lehmann R; Helfer-Hungerbuehler AK
PLoS One; 2019; 14(3):e0212811. PubMed ID: 30897117
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
[TBL] [Abstract][Full Text] [Related]
5. Enhanced transduction of mouse salivary glands with AAV5-based vectors.
Katano H; Kok MR; Cotrim AP; Yamano S; Schmidt M; Afione S; Baum BJ; Chiorini JA
Gene Ther; 2006 Apr; 13(7):594-601. PubMed ID: 16341060
[TBL] [Abstract][Full Text] [Related]
6. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
7. CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells.
Zhang Y; Chirmule N; Gao Gp; Wilson J
J Virol; 2000 Sep; 74(17):8003-10. PubMed ID: 10933709
[TBL] [Abstract][Full Text] [Related]
8. Complement is an essential component of the immune response to adeno-associated virus vectors.
Zaiss AK; Cotter MJ; White LR; Clark SA; Wong NC; Holers VM; Bartlett JS; Muruve DA
J Virol; 2008 Mar; 82(6):2727-40. PubMed ID: 18199646
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy.
Wu JQ; Zhao WH; Li Y; Zhu B; Yin KS
Virology; 2007 Nov; 368(2):309-16. PubMed ID: 17675129
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of adeno-associated virus serotype 2 (AAV2) and AAV8 capsid antigen presentation in vivo are identical.
He Y; Weinberg MS; Hirsch M; Johnson MC; Tisch R; Samulski RJ; Li C
Hum Gene Ther; 2013 May; 24(5):545-53. PubMed ID: 23534873
[TBL] [Abstract][Full Text] [Related]
11. Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice.
Passini MA; Watson DJ; Vite CH; Landsburg DJ; Feigenbaum AL; Wolfe JH
J Virol; 2003 Jun; 77(12):7034-40. PubMed ID: 12768022
[TBL] [Abstract][Full Text] [Related]
12. Pseudotyped adeno-associated viral vectors for gene transfer in dermal fibroblasts: implications for wound-healing applications.
Balaji S; King A; Dhamija Y; Le LD; Shaaban AF; Crombleholme TM; Keswani SG
J Surg Res; 2013 Sep; 184(1):691-8. PubMed ID: 23590866
[TBL] [Abstract][Full Text] [Related]
13. Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.
Chai Z; Sun J; Rigsbee KM; Wang M; Samulski RJ; Li C
J Control Release; 2017 Sep; 262():348-356. PubMed ID: 28789965
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of PARP-1 and NF-κB signaling downregulates immune response against recombinant AAV2 vectors during hepatic gene therapy.
Hareendran S; Ramakrishna B; Jayandharan GR
Eur J Immunol; 2016 Jan; 46(1):154-66. PubMed ID: 26443873
[TBL] [Abstract][Full Text] [Related]
15. Gene delivery to the vasculature mediated by low-titre adeno-associated virus serotypes 1 and 5.
Sen S; Conroy S; Hynes SO; McMahon J; O'Doherty A; Bartlett JS; Akhtar Y; Adegbola T; Connolly CE; Sultan S; Barry F; Katusic ZS; O'Brien T
J Gene Med; 2008 Feb; 10(2):143-51. PubMed ID: 18067196
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.
Boutin S; Monteilhet V; Veron P; Leborgne C; Benveniste O; Montus MF; Masurier C
Hum Gene Ther; 2010 Jun; 21(6):704-12. PubMed ID: 20095819
[TBL] [Abstract][Full Text] [Related]
17. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.
Gao GP; Alvira MR; Wang L; Calcedo R; Johnston J; Wilson JM
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11854-9. PubMed ID: 12192090
[TBL] [Abstract][Full Text] [Related]
18. Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets.
Wang L; Figueredo J; Calcedo R; Lin J; Wilson JM
Hum Gene Ther; 2007 Mar; 18(3):185-94. PubMed ID: 17324107
[TBL] [Abstract][Full Text] [Related]
19. Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders.
Pañeda A; Vanrell L; Mauleon I; Crettaz JS; Berraondo P; Timmermans EJ; Beattie SG; Twisk J; van Deventer S; Prieto J; Fontanellas A; Rodriguez-Pena MS; Gonzalez-Aseguinolaza G
Hum Gene Ther; 2009 Aug; 20(8):908-17. PubMed ID: 19419275
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
